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LOMA LINDA UNIVERSITY 
CENTER FOR 
CHRISTIAN BIOETHICS 
Lorna Linda Offers Master of Arts in 
Biomedical and Clinical Ethics and Assists 
Claremont with Theological Degrees 
Beginning in the Fall of 1993, Lorna Linda University will 
:lccept qualified students into a course of study leading to the 
!1aster of Arts in Biomedical and Clinical Ethics. This new 
program is distinctive in at least two ways. First, it integrates 
the increasingly separate worlds of biomedical ethics ("issues") 
on the one hand and clinical ethics ("cases") on the other. 
Second, it explores these matters from Christian points of view 
that are neither dogmatic nor doctrinaire. 
Since the Fall of 1991, a cooperative arrangement has 
existed between Lorna Linda and the School of Theology at 
Claremont that has enabled a number of students at the multi-
denominational seminary to attend classes and receive clinical 
experience at Lorna Linda University Medical Center. These 
students have worked primarily with M. Jerry Davis, Director 
of the office of chaplains at Lorna Linda and David R. Larson, 
Co-Director of LLU's Center for Christian Bioethics. 
The School of Theology at Claremont is a seminary of the 
United Methodist Church with more than four hundred stu-
dents and twenty-eight faculty who come from more than fifty 
different religious traditions and denominations. It offers 
courses of study leading to the Master of Divinity and Doctor 
of Ministry degrees as well as the Master of Arts and Doctor of 
Philosophy degrees. 
The programs at Lorna Linda and at Claremont are offered, 
governed and granted by institutions of higher learning that 
are independent of each other in every way. Co-operative 
arrangements have been established, however, that enable 
oma Linda students to take selected classes and seminars at 
~laremont and for Claremont students to participate in courses 
and gain clinical experience at Lorna Linda. This arrange-
ment enables theological students to study on a health sci-
ences campus and for students of the health professions to 
study on a theological campus. 
It is possible for students in virtually any of Claremont's 
programs to spend some time at Lorna Linda. But advanced 
students in Claremont's doctoral programs may find it espe-
cially useful to take advantage of Lorna Linda's unique op-
portunities in the areas of biomedical and clinical ethics as well 
as pastoral care and clinical ministry. 
Further information about the M A program in Biomedical 
and Clinical Ethics at Lorna Linda starts on page 2 of this issue. 
Information about the Claremont PhD program in Theology 
and Personality, with an emphasis in Pastoral Counseling, 
including a possible concentration in biomedical and clinical 
ethics, starts on page 6. Those who wish additional informa-
tion about the Lorna Linda program should contact Barton 
Rippon, dean of the Graduate School, Lorna Linda Univer-
sity, Lorna Linda, California 92350. 
Those who wish more information about the Claremont 
programs should contact Allen J. Moore, Dean and Vice 
President for Academic Affairs, School of Theology at 
Claremont, 1325 North College Avenue, Claremont, CA 91711-
3199. 
The Master of Arts at Lorna Linda 
The purpose of the course of graduate study leading to a 
Master of Arts in Biomedical and Clinical Ethics is to prepare 
qualified persons to engage in education, research and service 
pertinent to the moral challenges posed by, and experienced 
within, the various forms of medical inquiry and therapy. 
Upon the completion of this degree, many students will 
turn or return to one of the medical professions. Some will 
pursue doctoral degrees in biomedical and clinical ethics. 
Some will seek advanced degrees in law, social work, ministry, 
psychology and related fields. A few may find part-time or full-
time employment as ethics consultants and educators in health-
care institutions or agencies. All will proceed to their next 
academic or professional assignments with a thorough under-
standing of Christian ethical points of view and their pertinence 
to medical care, research and education. 
The Program in Biomedical and Clinical Ethics is admin-
istered by the Faculty of Religion through the Graduate 
School. It thereby draws upon resources in many sectors of the 
campus. In addition to the five professional schools within 
Loma Linda University, and a number of departments within 
Loma Linda University Medical Center and Loma Linda 
University Children's Hospital, these resources include the 
Center for Health Promotion, the Center for Christian Bioeth-
ics and the Behavioral Medicine Center. 
The Program in Biomedical and Clinical Ethics is sup-
ported by the Center for Christian Bioethics in a variety of 
ways. The Center's Thompson Library, a constantly growing 
specialized collection with approximately 1,500 volumes to 
date, aims to become one of the most comprehensive libraries 
of materials in biomedical and clinical ethics on the Pacific 
Slope. These materials, which are an especially valuable 
resource for graduate students, supplement the related hold-
ings in the primary libraries of LLU and nearby institutions. 
Admission 
In addition to meeting admission requirements for the 
Graduate School, the applicant must: 
1. Propose clear personal and professional goals and 
ways in which the Program in Biomedical and Clinical Ethics 
may facilitate their realization and; 
2. Persuade the admissions committee by previous ac-
complishments that he or she is able and willing to reach these 
goals and to make a distinguished contribution to the field. 
Course Requirements 
In order to receive the Master of Arts in Biomedical and Clinical 
Ethics from Lorna Linda University, each student must: 
1. Complete a minimum of 48 units of course work as 
herein specified with an overall grade point average of "B" 
or better, with no grade lower than a "C," and with no grade 
in a required course lower than a "B-." At least 32 units must 
be in approved courses numbered 500-699 or their equivalent. 
The required curriculum will be as follows: 
2 
RELE 504 Research Methods 
RELE 524 Christian Bioethics ( RELE 548 Christian Social Ethics 
RELE 554 Clinical Intensive in Bio-
medical Ethics I 
RELE 555 Clinical Intensive in Bio-
medical Ethics II 
RELE 577 Theological Ethics 
RELE 588 Types of Ethical Theory 
RELE 697 Independent Research 
RELE 698 Thesis or 
Approved Electives 
2. Students are able to transfer up to 8 units of approved 
courses from other institutions into LLU's Program in Bio-
medical and Clinical Ethics. Such opportunities are available 
at nearby institutions such as La Sierra University, Redlands 
University, University of California at Riverside, School of 
Theology at Claremont, and Fuller Theological Seminary. In 
addition, prior or current students in LLU's other post-bacca-
laureate degree programs will be able to petition for credit in 
this curriculum for up to 12 units of courses completed in their 
professional studies that are directly related to biomedical and 
clinical ethics. An illustrative list of such courses will be made 
available upon request. 
continued on page 6 
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( Depo-Provera: 
Contraceptive Dream or Nightmare? 
A Gynecologist's Perspective 
Elvonne A. Whitney, MD 
Assistant Professor 
Reproductive Endocrinology 
Department of Gynecology and Obstetrics 
Loma Linda University 
Loma Linda, California 
On October 29, 1992, the US Food and Drug Administra-
tion approved the use of Depo-Provera for contraception in 
the USA. It has been previously approved for other medical 
indications in this country, and has a long history of contracep-
tive use worldwide. The recent FDA approval has sparked 
controversy concerning the use of Depo-Provera for contra-
ception, and about contraception in general. This discussion 
addresses the medical aspects of contraception, and Depo-
Provera specifically. 
Unwanted pregnancy is a common problem, and the search 
{or an ideal contraceptive continues. Such a contraceptive 
would have several important characteristics: ease of use and 
compliance, minimal intervention needed by medical per-
sonnel, no need for coitus-related action, ease of return to 
fertility, protection against sexually-transmitted disease, and 
an excellent safety profile. No currently available contracep-
tive ideally meets all these criteria. However, Depo-Provera 
is an important addition to the spectrum of contraceptives 
available because of its unique combination of benefits. Data 
indicate it is the most effective reversible method of fertility 
regulation available today. 
Depo-Provera has been used over the past three decades in 
over 30 million women in 90 countries, affording opportunity 
to study the efficacy and safety of the drug. 
Depo-Provera, or depot medroxyprogesterone acetate 
(DMPA), is a long-acting injectable progestogen highly effec-
tive in preventing pregnancy when given every three months. 
Less than 1 percent of women become pregnant during the 
first year of using Depo-Provera. This rate is comparable to 
sterilization and subdermal implants, and significantly less 
than that for oral contraceptives (3%), the IUD (3%), or barrier 
methods (generally over 15%). There is no need to comply 
with either daily or coitus-related action to prevent pregnancy 
with this method. Depo-Provera affords complete contra-
--eptive privacy to the woman for whom this is important, and 
_ :0 medical intervention is necessary to discontinue this method. 
Depo-Provera is well-tolerated in extensive clinical trials. 
continued on page 4 
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Some Catholic Moral Reflections 
Father leremiah 1. McCarthy, PhD 
Academic Dean 
St. lohn 's Seminary 
Camarillo, California 
The approval of Depo-Provera, licensed in October, 1992, 
and available in January, 1993, raises a host of ethical consid-
erations. The ethical concerns that have surfaced thus far 
seem to fall into two categories: first, the medical risks 
associated with the medications and the potential for the 
abuse of poor and minority women by state government 
agencies; and second, the intrinsic significance of contracep-
tion as a personal and public practice, a conversation reflected 
in recent Catholic literature. 
Perhaps the most attractive feature of this medication 
according to the Medical Ethics Advisor, (February 1993), is the 
elimination of the fear of missing a daily dose of contraceptive. 
At this juncture, critical questions begin to emerge. With the 
elmination of this fear, the medications can readily be employed 
by governmental agencies who want to enforce restrictions on 
unwanted pregnancies as a matter of public policy. This issue 
is of serious concern to the staff ethicists involved with the 
Hastings Center Project on the effects of long-term contra-
ceptives. While the policy goals may be worthwhile, such as 
reducing the incidence of teenage pregnancy, restricting the 
reproductive freedom of an abusive mother, or increasing the 
likelihood that poor women may avoid the economic burden 
of additional children, the ethical concern is the threat to 
individual liberty resulting from such policy initiatives. 
According to Ellen Moskowitz, a member of the Hastings 
Project, "the potential for coercion comes in when, in the zeal 
to achieve a policy goal, women are encouraged, manipulated, 
or perhaps forced to use these long-term contraceptives" 
(Advisor, p. 17). There is evidence for such concerns: Judges 
in Texas and California who have made Norplant a condition 
for probation in the case of women convicted of child abuse, 
the consideration of legislation along similar lines by 13 states 
although none has implemented such legislation, and the 
decision by Baltimore health officials to provide N orplant in 
school-based clinics beginning in January, 1993. As noted, the 
Hastings Center has commissioned a two-year study with the 
goal of making specific policy recommendations. A key focus 
continued on page 4 
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Depo Provera: Whitney (Continued from page 3) 
The most common side effects are menstrual changes. Most 
women experience irregular bleeding patterns, but their fre-
quency decreases with continued use. After one year 57 
percent of women reported amenorrhea, which many women 
felt was a convenient benefit once they understood that this 
indicated no medical problem. With long-term use up to 23 
percent of patients elected to discontinue use because of 
menstrual changes. 
Other side effects include weight gain, headache, ner-
vousness, dizziness, and fatigue. Weight gain averages 5.4lbs. 
after one year of use, and up to 161bs. after 6 years of use. The 
other side effects mentioned are less frequent, often short-
lived, and women usually felt these were minor when compared 
to the convenience of using Depo-Provera. 
One reason for- the long delay in FDA approval of Depo-
Provera was a concern about the increased risk of cancer with 
long-term use. It is now felt that initial evidence linking its use 
to breast cancer in beagle dogs does apply to humans. Long-
term human studies and other animal studies have not reached 
similar conclusions. The relative risk of breast cancer with 
long-term Depo-Provera use has been calculated at 1.21 (95% 
C.1. 0.96-1.52), and is not statistically significant. There may 
be a small group of women under age 35 already at increased 
risk of breast cancer who show an increase in breast cancer 
during the first three months of using Depo-Provera. This 
increase does not continue with longer use. No increase in 
cancer of the ovary or cervix has been documented, and there 
is a significant decrease in cancer of the endometrium. 
One study in New Zealand showed a decreased bone 
density in those women who had used Depo-Provera for five 
years compared to control women. This appeared to be 
reversible after stopping Depo-Provera, and its significance is 
unclear. Further study is needed to determine whether an 
increased risk for osteoporosis actually is present with long-
term use of Depo-Provera. 
Depo-Provera is felt safe to use in breast-feeding mothers 
when started six weeks postpartum, and can be started im-
mediately after delivery in non-breast-feeding women. There 
have been no reports of congenital defects in the few fetuses 
exposed to this contraceptive during pregnancy, and their 
growth and development is normal at least through puberty. 
Also, because of its high effectiveness, Depo-Provera is an 
attractive option for women taking highly teratogenic medi-
cations. 
Injectable contraceptives such as Depo-Provera do not 
permanently affect fertility. While for complete contraceptive 
effectiveness injections are needed every twelve weeks, 
ovulation and fertility do not immediately return at that point. 
However, within one year after the last injection almost 70 
percent of women had conceived, and more than 90 percent 
within two years. There is no correlation between the length 
of use or number of injections and the time to return of 
ovulation and fertiltiy. 
continued on page 5 
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Depo Provera: McCarthy (Continuedfrom page 3) 
is the issue of coercion itself. The offer of financial incentiver 
to use the medications, or the choice of either jail time d, 
probation if the woman agrees to use a contraceptive medica-
tion, may be a Hobson's choice, that is, no choice at all. The 
specter of the eugenics movement which clouded the move-
ment for birth control in the early part of the century is also 
reason for pause. According to Moskowitz, "we do have an 
important history in this country to look to control of reproduc-
tion to solve intractable social problems"(Advisor, p. 17). 
I do not find the benefits of 
long-term chemical measures 
to be compelling or persuasive. 
In order to forestall the use of these medications for 
purposes not intended by the manufacturers, clear protocols 
for informed consent and careful counseling must be in place. 
With teenagers particularly, education about the risks is im-
perative, because of the danger that increased sexual activity 
will escalate the risks of becoming HIV positive. The likeli-
hood that teenagers will avail themselves of condoms is 
questionable, and here the discussion joins the debate over 
school-based clinics and contraceptives, a much controverte, 
public policy matter which I will briefly address at the con-
clusion. 
Ancillary questions also emerge with respect to poor women 
who may lack the resources to have the medications either 
removed or continued, and the importance of insuring that 
physicians do not co-opt the decision-making authority of 
women by overriding their concerns with larger public policy 
interests. 
The ethical issues raised thus far deal with the potential for 
abuse, and the appropriate strategy for addressing them appears 
to lie in well-formulated protocols insuring informed consent, 
freedom from coercion, and careful, thorough counseling. 
However, there is another set of concerns that deals with the 
substantive issue of contraception itself. 
Quite apart from the potential abuses of long-term con-
traceptives ranging from judicially mandated sterilization, or 
racially motivated sterilization, and the threat to womens' 
choice and health in developing countries, (i.e., lack of ac-
cessibility to skilled medical professionals, lack of follow-up 
medical care, and poor antiseptic conditions in "Third World" 
clinics), the ethical presupposition underlying contraception 
itself is problematic in Catholic moral thought. 
Sister Renee Mirkes, writing in the April, 1991, issue of 
Ethics and Medics, argues that contraception is morally objec-
tionable because it "deliberately acts against the basic humar 
good of procreation, a good that, by God's arrangement, 1 
meant to be fostered or respected in every engagement in or 
continued on page 5 
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Depo Provera: Whitney (Continued from page 4) 
Depo-Provera's mechanism of action involves inhibiting 
(he secretion of pituitary gonadotropins (FSH, LH) which are 
necessary for normal follicular development in the ovary, and 
thereby prevents ovulation. The normal endometrial and 
cervical changes that occur in preparation for a pregnancy are 
also suppressed. These actions prevent pregnancy from oc-
curring, and thus Depo-Provera is not an abortifacient. 
The few contraindications for using Depo-Provera include 
pregnancy or undiagnosed vaginal bleeding. It is not a good 
choice for women who cannot or will not return for injections 
every three months, or those unwilling to experience the 
menstrual changes associated with Depo-Provera. On the 
other hand, it is safe and attractive for many women for whom 
estrogen-containing contraceptives are not an option, such as 
those with hyperte'nsion, renal or hepatic disease, vascular 
disease, uterine fibroids, and endometriosis. Its convenience 
makes it an attractive option for institutionalized or mentally 
retarded women for whom other contraceptive methods are 
difficult. It is of course imperative that safeguards be followed 
in the use of Depo-Provera in women who may not be able to 
give personal informed consent. 
While not for every woman, the Depo-Provera method 
offers to many an attractive, affordable, and convenient method 
of pregnancy control. 
References: 
Kleinman RL, Editor. Injectable Contraception Issue, JPPF 
.1edical Bulletin. 1992,26: 1-5. 
/ Trussell], Kost K. Contraceptive failure in the United States: A 
critical review of the literature. Stud Fam Plann. 1987;18:237-83. 
WHO Collaborative Study of Neoplasia and Steroid Contracep-
tives. Breast cancer and depot-medroxyprogesterone acetate: A 
Multinational study. Lancet. 1991;338:833-838 .• 
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abstention from marital intercourse"(p. 2). In other words, 
contraception remains morally problematic from a Catholic 
perspective because it sunders the linkage between the uni-
tive and procreative meanings of human sexual gesture. This 
argument does not rest upon a denial of the empirical fact that 
not every act of intercourse is "naturally" open to the possibil-
ity of procreation, nor does the Catholic argument contend 
that the only valid expression of marital sexual intimacy can 
only occur in the context of a clearly procreative intention. 
Rather, the point of the Catholic thesis is that basic human 
goods, including procreation and marital intimacy, cohere in 
an interdependent moral order in which the intrinsic value of 
each "bonum" or "human good" is integrally respected. Pur-
suing this line of thinking, then, attending to natural biological 
rhythms to space the size of the family underscores the moral 
responsibility of both husband and wife, facilitates communi-
'ation and awareness of the fertility and reproductive power 
.:he spouses possess, and, especially in the form of natural 
family planning (not to be confused with an outmoded and 
biologically inadequate "rhythm" method), respects the 
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woman's biological integrity by avoiding the harmful side 
effects of chemical contraception. 
This argument has its detractors, of course, even in the 
community of Catholic moralists, but it also has its champions, 
and space precludes a full elaboration of all of the issues 
involved. Nonetheless, I am intrigued by the growing recep-
tivity to the argument especially as the twenty-fifth anniver-
sary of the famous papal encyclical, H umanae Vitae, draws near. 
The argument has been vociferously and effectively defended 
by Janet Smith in her new book, Humanae Vitae, A Generation 
Later, and by Jacquelin Kasun in her volume, The War Against 
Population, The Economics and Ideology of Population ' Control. 
In conclusion, I find recourse to long-term contraceptive 
medications to rest on a flawed premise regarding the control 
of human fertility. All parties agree that it is morally respon-
sible to limit the size of the family under certain conditions, 
and to avoid pregnancy when it is clearly inappropriate, e.g., 
teenagers and others lacking the emotional, fiscal and personal 
maturity to raise a child. The disagreement lies with the 
means that are chosen. Measures which radically sunder the 
unitive and procreative meaning of human marital intercourse, 
are problematic from a Catholic perspective. In addition, use 
oflong-term contraceptives to solve complicated public policy 
issues such as increased welfare dependency or an escalation 
of teenage pregnancy substitutes technical means for a thor-
ough-going moral and human response. I am not naively 
suggesting that the answer lies in merely trumpeting the 
slogan, "just say no." Rather, I am urging an honest engage-
ment with the real issues that generate poverty and high risk, 
irresponsible sexual behavior. 
Research into teenage pregnancy, for example, clearly 
establishes a strong correlation between poor self-esteem and 
the need for personal validation through pregnancy (see the 
work by Eunice Kennedy Shriver which supports this con-
tention). Moreover, recourse to contraceptives to address this 
problem neglects the important work of cultivating skills for 
intimacy which can be taught and learned. Many thoughtful 
experts on the problem are rightly concerned that increasing 
access to contraceptives sends the wrong message to young 
people and contributes to an increase rather than a decrease in 
sexual activity. On this score, the recent findings of the Center 
for Disease Control in Atlanta detailing the increasingly early 
onset of sexual activity, and the report of the New York State 
Catholic Conference on sex education deserve close inspec-
tion. 
The use of long-term contraceptive medications is a re-
finement that raises ethical concerns endemic to the extensive 
conversation in the ethical literature about contraception itself. 
Given the proven effectiveness of natural family planning, I do 
not find the benefits of long-term chemical measures to be 
compelling or persuasive as a means of addressing public 
policy or pregnancy issues, and would urge that more attention 
be given to natural family planning, to moral education, es-
pecially education in skills for intimacy and responsible sexual 
behavior, as truly viable alternatives to Depo-Provera .• 
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Master of Arts at Lorna Linda University 
Faculty 
Wilber Alexander, PhD Michigan State University 1962 
Dean, Faculty of Religion; 
Professor of Theology and Clinical Ministry 
David R. Larson, DivEn School of Theology at Claremont 1973 
PhD Claremont Graduate School 1982 
Program coordinator; Associate Professor of Christian 
Ethics; Co-Director, Center for Christian Bioethics 
Leigh Bishop, MD University of Texas, Galveston 1980 
MA, University of California, Riverside 1992 
Associate Professor of Psychiatry 
Robert D. Orr, MD McGill University 1966 
Associate Professor of Family Medicine 
Director of Clinical Ethics, 
Lorna Linda University Medical Center; 
Co-Director, Center for Christian Bioethics 
Jack W. Provonsha, MD Lorna Linda University 1953 
PhD Claremont Graduate School, 1967 
Emeritus Professor of Philosophy of Religion 
and Christian Ethics 
James W. Walters, PhD Claremont Graduate School 1979 
Professor of Christian Ethics 
Associate Faculty 
Roy Branson, PhD Harvard University 1968 
Adjunct Professor of Christian Ethics 
Charles W. Teel, Jr., PhD Boston University 1972 
Adjunct Professor of Christian Ethics 
Lois Van Cleve, PhD Claremont Graduate School 1985 
Professor of Nursing 
Gerald R. Winslow, PhD Graduate Theological Union 1979 
Adjunct Professor of Christian Ethics 
Clinical Faculty 
Dennis deLeon, MD University of Tennessee, Memphis 1985* 
Assistant Professor of Family Medicine 
Clinical ethicist, Lorna Linda University Medical Center 
Leigh B. Genesen, RN, BA Northwestern University 1991" 
Instructor in Family Medicine . 
Clinical ethicist, Lorna l ... inda University Medical Center 
Steven B. Hardin, MD Lorna Linda University 1985 
Assistant Professor of Medicine 
*Anticipated academic appointment: July 1,1993. 
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Comprehensive Examinations 
Each student must pass five comprehensive written ex-
aminations within a single week. These examinations will test 
the student's ability to integrate and apply knowledge from 
the following areas: (1) philosophical ethics, (2) theological 
ethics, (3) social ethics, (4) biomedical ethics, and (5) clinical 
ethics. These examinations must be successfully completed 
before the student defends a thesis or its approved substitutes. 
Thesis or Project 
Each student must either prepare a thesis while registered 
for RELE 697 and RELE 698 or prepare three major papers of 
publishable quality in courses approved as substitutes by the 
guidance committee. The student must provide an oral defense 
of a thesis or three major papers that analyze specific issues, 
cases, dilemmas or themes in biomedical and clinical ethics. 
Students must declare whether they intend to write a thesis by 
the time they complete 12 quarter units in the program. 
The Doctor of Philosophy at 
Claremont 
The following is taken from the 1991-1993 School of Theology at 
Claremont bulletin, pages 38-41. 
The PhD program in Theology and Personality at STC is 
designed to prepare students for teaching in colleges or 
theological schools and for professional leadership in the 
church and society. It is a theological degree, a research 
degree, and a professional degree. It requires broad theologi-
cal knowledge and aims at preparing the student for the 
competent scholarly development of a special field of study in 
the context of the theological disciplines. The student is also 
expected to understand the methodological and epistemologi-
cal presuppositions of the field of concentration and to become 
capable of advancing the field through original research. 
The degree program emphasizes the professional appli-
cability of the field of research by correlating theoretical and 
practical course work and by implementing critical reflection 
on the nature of the interdependence of professional theory and 
practice, as well as on methods and procedures relevant to it. 
STC offers the PhD in Theology and Personality with an 
emphasis in either Pastoral Counseling or Religious Educa-
tion. The program in Counseling is designed to train students 
in the theory of research in the behavioral sciences with 
emphasis on counseling psychology, and its relationship to 
theology. In addition, students may prepare for specialized 
ministries in Pastoral Counseling at an advanced level. Such 
preparation may require more work than is prescribed in thf' 
basic 48 units. 
The program in Religious Education integrates theology 
with educational theory and practice. Students are expected 
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to achieve advanced competence in theological reflection as 
well as in educational practice and, through original research, 
'i> ~ake a contribution to the development of religious edu-
)atlOn. 
Both programs share a series of doctoral seminars in theol-
ogy and studies in the human sciences. A thorough knowledge 
of the history, literature, major theories, and methods of 
research in the field is expected by the completion of the 
program. 
All students are required to take an English Composition 
Skills examination on entrance to the program. Based on the 
evaluation of this exam, students may be required to take a 
course in English Composition Skills. 
Degree Requirements 
The PhD program requires General Examinations, lan-
guage and research requirements, course requirements, an 
internship, written and oral qualifying examinations, a dis-
sertation and oral defense. At least two semesters of 12 units 
or three semesters of 8 units are required as a residency 
requirement. These semesters need not be taken consecu-
tively. 
General Examinations 
The purpose of the General Examinations is to demonstrate 
~ompetence in five areas: 
,7 
1. One examination in Systematic Theology 
2. One examination in the field of emphasis: either 
Pastoral Counseling or Religious Education 
3. One examination in the Psychological Sciences 
4. Two examinations chosen from the following fields: 
a. Biblical Studies 
b. History of Christianity and Christian Thought 
c. Ethics and Society 
d. History of Religions 
Each student in the 48-unit PhD program is required to 
take at least three examinations during the exam week pre-
ceding the beginning of classes in the Fall, before formal study 
is begun. If the examinations are not passed, the student may 
expect to be assigned remedial work designed to bring the 
student to the level of competency presupposed by the PhD 
program. 
Each student entering under the 72-unit provision must 
take at least three examinations upon entrance to the program. 
Successful completion of these exams upon entrance may 
result in reduction of additional units required above the 48-
unit program. If three exams are passed, the program will be 
reduced by 12 units. If all five exams are passed upon 
entrance, the student will begin study under the terms of the 
'-8-unit PhD program . 
. ,' Each student who is admitted with an MA in an area other 
than theological studies and is requried to complete 40 units of 
additional course work in theological studies, must take and 
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pass three examinations before entering the final 48 units of 
the PhD program. The remaining two must be passed before 
registering for the final 24 units of PhD study. 
Language and Research Requirements 
Students must demonstrate a reading knowledge of either 
French or German. A second language or a research method 
appropriate to the student's dissertation is also required. One 
ofthese language or research tools must be completed prior to 
beginning the final 24 units of PhD study. 
Course Requirements 
A minimum of 48 units of course work must be completed 
at STC, and more units may be required. The course re-
quirements are as follows: 
Emphasis in Counseling 
Theology (12) 
Courses in one or two of the following areas: 
Systematic Theology 
Biblical Studies 
Cognate Field (8) 
Theological Ethics 
Church History 
Courses in an approved cognate field related to counseling, 
such as clinical psychology, developmental psychology, etc. 
The cognate field is ordinarily taken at Claremont 
Graduate School or with approval at the Department of 
Pastoral Services, Loma Linda Medical School. 
Pastoral Counseling (20) 
Courses distributed across supervised counseling (8 
units credit; 8 units audit), History, Psychopathology, 
and Psychotherapeutic Theory and Method. Supervised 
Counseling provides actual counseling experience under 
the supervision of STC professors at the Clinebell 
Institute. 
Departmental Seminars (8) 
Courses that are (1) relevant both to Pastoral Counseling 
and Religious Education, (2) integrative of theory and 
practice in theology and the human sciences, and (3) 
addressing common themes, including Psychology of 
Religion, Human Development, Practical Theology, 
Pastoral Assessment, and Research Methods. 
At least one course is to be a Theological Methods course. 
Students must take at least one-quarter of approved Clini-
cal Pastoral Education (CPE) prior to admission or during their 
PhD program. No unit credit is awarded for this requirement. 
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Emphasis in Education 
Theology (12) 
Courses in one or two of the following areas: 
Systematic Theology 
Biblical Studies 
Cognate Field (8) 
Theological Ethics 
Church History 
Courses in an approved cognate field related to Education. 
The cognate field is ordinarily taken at Claremont Graduate 
School. 
Religious Education (20) 
Courses distributed across pedagogical theory, history, and 
social psychological theory. 
Department Seminars (8) 
Courses that are (1) relevant both to pastoral Counseling 
and Religious Education, (2) integrative of theory and 
practice in theology and the human sciences, and (3) 
addressing common themes, including Psychology of Re-
ligion, Human Development, Practical Theology, Pastoral 
Assessment, and Research Methods. 
At least one course is to be a Theological Methods course. 
Internship: 
At least one semester in full-time advanced internship or 
field-based research in Religious Education. 
Qualifying Exams 
Qualifying Exams are taken when the student has com-
pleted all course work requirements, the research tool ex-
pectations, and the Internship/Residency. The qualifying 
exams cover five areas, following the areas of the course work 
requirements. Five written examinations, each four hours in 
length, are required. An oral examination will be conducted by 
the student's Guidance Committee. (See Academic Policy 
Handbook for specific requirements.) 
Dissertation Proposal 
At the conclusion of the qualifying examinations, the 
student will present a dissertation proposal to the examining 
committee. After the proposal has been approved by the 
Guidance Committee, it will be submitted to the Committee 
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on Academic Procedures. This Committee then recommends 
the student to the faculty for advancement to Candidacy for 
the PhD degree. ( 
Dissertation 
The student is required to present an acceptable dissertation 
based upon independent research. The dissertation must 
demonstrate the student's capacity to relate resources from at 
least one of the classical theological disciplines (Bible, History 
of Christianity, Theology, or Ethics) and the resources from 
Counseling or Education. 
The PhD candidate must successfully complete the final 
oral examination related to the dissertation research. The final 
oral examination will be conducted by the Guidance Committee 
plus an outside examiner representing the faculty as a whole. 
Now Available! 
Abortion: 
Ethical Issues &Options 
Edited by David R. Larson 
16 thought-provoking essays 
1992 SDA Abortion Guidelines 
Completely indexed 
$9.95 
Shipping/Handling$3.00 for the first book, 
and 50 cents for each additional book. 
(CA residents add 7.75% sales tax) 
Abortion Book 
Lorna Linda University 
Center for Christian Bioethics 




Permit No. 6 
Lorna Linda, CA 
